Stock listing
DNA Stock Price, News, Filings & Events — Ginkgo Bioworks Holdings, Inc.
Selected listing: DNA · NYSE · USD · US
This page tracks Ginkgo Bioworks Holdings, Inc.'s DNA:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DNA:NYSE. DNA:NYSE is the stock-level entry point for investors researching Ginkgo Bioworks Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ginkgo Bioworks Holdings, Inc. is a public company traded under the ticker DNA in the American market. The company has a market capitalization of approximately $480.79 million. Ginkgo Bioworks specializes in using biotechnology to design custom microbes for various applications across different industries.
- Ticker
- DNA:NYSE
- Asset type
- Stock
- Market cap
- $498.3M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NYSE
- Currency
- USD
Ginkgo Bioworks Holdings, Inc. DNA:NYSE stock context
This page tracks Ginkgo Bioworks Holdings, Inc.'s DNA:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DNA:NYSE. DNA:NYSE is the stock-level entry point for investors researching Ginkgo Bioworks Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ginkgo Bioworks Holdings, Inc. is a public company traded under the ticker DNA in the American market. The company has a market capitalization of approximately $480.79 million. Ginkgo Bioworks specializes in using biotechnology to design custom microbes for various applications across different industries.
Latest news from Ginkgo Bioworks Holdings, Inc.
Genentech Announces Manufacturing Expansion in Hillsboro, Oregon
August 20, 2026
Ginkgo Bioworks : Expands Autonomous Lab Network to Caltech, MIT, Maryland and Northwestern
August 5, 2026
Ginkgo Bioworks : and Acies Bio Partner to Expand Global Access to High-Performance Aspergillus niger Strains for Protein Production
August 3, 2026
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic P...
May 26, 2026
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
May 7, 2026
Research Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. investor report
Review AI stock analysis and investor report context for DNA:NYSE.
Ginkgo Bioworks Holdings, Inc. company profile
View the public company page for Ginkgo Bioworks Holdings, Inc. on 6ix.
Ginkgo Bioworks Holdings, Inc. news
Read company news and market updates connected to Ginkgo Bioworks Holdings, Inc..
Ginkgo Bioworks Holdings, Inc. investor events
Find investor webinars, events, and replay context for Ginkgo Bioworks Holdings, Inc..
Alternate listings
9L40:TRADEGATE
DE · EUR
Alternate listing for Ginkgo Bioworks Holdings, Inc.; the primary context on this page is DNA:NYSE.
DNA:BMV
MX · MXN
Alternate listing for Ginkgo Bioworks Holdings, Inc.; the primary context on this page is DNA:NYSE.
DNA:BOATS
US · USD
Alternate listing for Ginkgo Bioworks Holdings, Inc.; the primary context on this page is DNA:NYSE.
A40KL9:GETTEX
DE · EUR
Alternate listing for Ginkgo Bioworks Holdings, Inc.; the primary context on this page is DNA:NYSE.
DNA:BIVA
MX · MXN
Alternate listing for Ginkgo Bioworks Holdings, Inc.; the primary context on this page is DNA:NYSE.